Firms

CARMA FUND

CARMA FUND

carma-fund.com

CARMA FUND is a Munich- and Frankfurt-based early-stage life-science and healthcare investor managed by CARMA FUND Management GmbH. Initiated with Ascenion and academic technology-transfer partners, it backs therapeutics, diagnostics, medical devices, digital health and research technologies in Europe. Its long fund term and flexible investment structures support academic spin-offs and extended biomedical development timelines. Relevant holdings include AI-powered pathology company Aignostics and neuroscience companies CereGate and Elkedonia. The manager reports EUR 56 million under management for CARMA FUND I.

Founded
—
Type
Venture capital

Funds1

  • CARMA FUND I€56M

    Early-stage life-science and healthcare fund with a long term and flexible investment structures. Current manager website reports EUR56 million under management; first closing in June2022 exceeded EUR47 million. No exact final-closing date is published, and EUR56 million is not assigned to the first close.

Team

Operations and support

Christian LeikertManaging Partner
Claus SchulteSenior Investment Manager
Martin MüllerSenior Investment Manager
Martin RaditschManaging Partner
Thomas HankeVenture Partner

Co-investing

Boehringer Ingelheim Venture Fund
High-Tech Gründerfonds
IBB Ventures
Wellington Partners
Andera Partners

Investments